Virus-encoded superantigens

Microbiological Reviews

Volumn 60, Issue 3, 1996, Pages 473-482

  Huber, B T ^a   Hsu, P N ^a   Sutkowski, N ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN; VIRUS ANTIGEN;

CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; RABIES VIRUS; REVIEW; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS TRANSMISSION;

EID: 0029806898     PISSN: 01460749     EISSN: None     Source Type: Journal    
DOI: 10.1128/mmbr.60.3.473-482.1996     Document Type: Review

References (92)

1. Acha-Orbea, H., W. Held, G. A. Waanders, A. N. Shakhov, L. Scarpellino, R. K. Lees, and H. R. MacDonald. 1993. Exogenous and endogenous mouse mammary tumor virus superantigens. Immunol. Rev. 131:5-25.
2. Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Müller, A. Vessaz-Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, M. Sarafidou, H. R. MacDonald, and H. Diggelmann. 1991. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature (London) 350:207-211.
3. Ambroziak, J. A., D. J. Blackbourn, B. G. Herndier, R. G. Glogau, J. H. Gullett, A. R. McDonald, E. T. Lennette, and J. A. Levy. 1995. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268:582-583.
4. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207-211.
5. Beutner, U., W. N. Frankel, M. S. Cote, J. M. Coffin, and B. T. Huber. 1992. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad. Sci. USA 89:5432-5436.
6. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
7. Beutner, U., B. McLellan, E. Kraus, and B. T. Huber. 1996. Lack of MMTV superantigen presentation in MHC class II deficient mice. Cell. Immunol. 168:141-147.
8. Bijlmakers, M. J., P. Benaroch, and H. L. Ploegh. 1994. Assembly of HLA.DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J. 13:2699-2707.
9. + T cells mediated by MHC class II-bearing stromal cell in the thymic cortex. Nature (London) 341:649-651.
10. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
11. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature (London) 350:203-207.
12. Choi, Y., P. Marrack, and J. W. Kappler. 1992. Structural analysis of a mouse mammary tumor virus superantigen. J. Exp. Med. 175:847-852.
13. Cohen, J. C., and H. E. Varmus. 1979. Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature (London) 278:418-423.
14. Dellabona, P., J. Peccoud, J. Kappler, P. Marrack, C. Benoist, and D. Mathis. 1990. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121.
15. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155-165.
16. + T cells is restricted to certain Vβ subsets. Proc. Natl. Acad. Sci. USA 92:5563-5567.
17. Donehower, L. A., B. Fleurdelys, and G. L. Hager. 1983. Further evidence for the protein-coding potential of the mouse mammary tumor virus long terminal repeat: nucleotide sequence of an endogenous proviral long terminal repeat. J. Virol. 45:941-949.
18. Donehower, L. A., A. L. Huang, and G. L. Hager. 1981. Regulatory and coding potential of the mouse mammary tumor virus long terminal redundancy. J. Virol. 37:226-238.
19. Driscoll, J., M. G. Brown, D. Finley, and J. J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature (London) 365:262-264.
20. Dyson, P. J., A. M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature (London) 349:531-532.
21. Festenstein, H. 1973. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant. Rev. 15:62-88.
22. Fleischer, B. 1991. Stimulation of human T cells by microbial 'superantigens'. Immunol. Res. 10:349-355.
23. Fleischer, B., and H. Schrezenmeir. 1988. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp Med. 167:1697-1707.
24. Frankel, W. N., C. Rudy, J. M. Coffin, and B. T. Huber. 1991. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature (London) 349:526-528.
25. Gaugler, B., C. Langlet, J. M. Martin, V. A. Schmitt, and A, Guimezanes. 1991. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TCR/ CD3 antibodies. Eur. J. Immunol. 21:2581-2589.
26. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (London) 378:457-462.
27. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
28. Hammer, J., E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353-2358.
29. Hara, T., L. K. L. Jung, J. M. Bjorndahl, and S. M. Fu. 1986. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-telradecanoyl phorbol-13-acetate, mitogens, and antigens. J. Exp. Med. 164:1988-2005.
30. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
31. Held, W., G. A. Waanders, A. N. Shakhow, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
32. Henle, G., W. Henle, and V. Diehl. 1968. Relation of Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 59:94-101.
33. Herman, A., G. Croteau, R.-P. Sekaly, J. Kappler, and P. Marrack. 1990. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J. Exp. Med. 172:709-717.
34. Hsu, P. N., and B. T. Huber. 1995. Gazing into the crystal ball. Curr. Biol. 5:235-237.
35. Hsu, P. N., P. R. Wolf, B. McLellan, H. L. Ploegh, and B. T. Huber. Association of mouse mammary tumor virus superantigen with MHC class II molecules in the endoplasmic reticulum during biosynthesis. Submitted for publication.
36. Janeway, C. J., and M. E. Katz. 1985. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidircctionality, new strain combinations, and the role of Ia antigens. J. Immunol. 134:2057-2063.
37. Jardelzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. Chi, C. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with suptrantigen. Nature (London) 368:711-718.
38. Kappler, J., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273-280.
39. Kappler, J. W., U. Staerz, J. White, and P. C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (London) 332:35-40.
40. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 1109-1162. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fundamental virology, 3rd ed. Lippincott-Raven.
41. Kim, J., R. G. Urban, J. L. Strominger, and D. C. Wiley. 1995. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule, HLA-DR1. Science 266:1870-1874.
42. Knight, A. M., G. B. Harrison, R. J. Pease, P. J. Robinson, and P. J. Dyson. 1992. Biochemical analysis of the mouse mammary tumor virus long terminal repeat product. Evidence for the molecular structure of an endogenous superantigen. Eur. J. Immunol. 22:879-882.
43. Korman, A. J., P. Bourgarel, T. Meo, and G. E. Rieckhof. 1992. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 11:1901-1905.
44. Lafon, M., M. Lafage, A. A. Martinez, R. Ramirez, F. Vuillier, D. Charron, V. Lotteau, and A. D. Scott. 1992. Evidence for a viral superantigen in humans. Nature (London) 358:507-510.
45. Lafon, M., D. Scott-Algara, E. Jouvin-Marche, and P. N. Marche. 1993. Superantigenicity of rabies virus nucleocapsid in humans and mice. Curr. Commun. Cell Mol. Biol. 7:117-138.
46. Lafon, M., D. Scott-Algara, P. N. Marche, P.-A. Cazenave, and E. Jouvin-Marche. 1994. Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen. J. Exp. Med. 180:1207-1215.
47. Liu, H., M. A. Lampe, M. V. Iregui, and H. Cantor. 1991. Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways. Proc. Natl. Acad. Sci. USA 88:8705-8709.
48. Lynch, D. H., R. E. Gress, B. W. Needleman, S. A. Rosenberg, and R. J. Hodes. 1985. T cell responses to Mls determinants are restricted by cross-reactive MHC determinants. J. Immunol. 134:2071-2078.
49. + thymocytes controlled by MHC class II gene products. Nature (London) 336:471-473.
50. a-encoded antigens. Nature (London) 332:40-45.
51. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
52. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature (London) 349: 524-526.
53. Miller, G. 1989. The Epstein-Barr virus. In B. Fields and D. M. Knipe (ed.), Fields virology. Raven Press, New York.
54. Miyashita, E. M., B. Yang, K. M. C. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601.
55. Moore, P. S., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332:1181-1185.
56. Moss, D. J., A. B. Rickinson, and J. H. Pope. 1978. Long-term T cell-mediated immunity in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int. J. Cancer 22: 662-668.
57. Mottershead, D. G., P. N. Hsu, R. G. Urban, J. L. Strominger, and B. T. Huber. 1995. Direct binding of the Mtv-7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity 2:149-154.
58. Murray, W. S. 1963. MA/MyJ strain of the marsh albino mouse. J. Natl. Cancer Inst. 30:605-610.
59. Nilsson, K., G. Klein, W. Henle, and G. Henle. 1971. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer 8:443-450.
60. O'Rourke, A. M., M. F. Mescher, and S. R. Webb. 1990. Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants. Science 249:171-174.
61. Park, C. G., M. Y. Jung, Y. Choi, and G. M. Winslow. 1995. Proteolytic processing is required for viral superantigen activity. J. Exp. Med. 181:1899-1904.
62. + T cells by conventional antigen and Mls superantigen. Proc. Natl. Acad. Sci. USA 88:2736-2739.
63. Payne, J., and B. T. Huber. 1992. Minor lymphocyte stimulatory antigen-bearing stimulator cells require lipopolysaccharide activation to induce programmed cell death in T cell hybridomas. J. Immunol. 149:1571-1576.
64. Pullen, A. M., Y. Choi, E. Kushnir, J. Kappler, and P. Marrack. 1992. The open reading frames in the 3′ long terminal repeats of several mouse mammary tumor virus integrants encode Vβ3-specific superantigens. J. Exp. Med. 175:41-47.
65. Reinherz, E. L., C. O'Brien, P. Rosenthal, and S. F. Schlossman. 1980. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J. Immunol. 125:1269-1274.
66. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091-1100.
67. Rochford, R., and D. E. Mosier. 1995. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J. Virol. 69:150-155.
68. Rudy, C. K., E. Kraus, E. Palmer, and B. T. Huber. 1992. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor proviras that is distinct from Mtv-7. J. Exp. Med. 175:1613-1621.
69. Saito, I., B. Servenius, T. Compton, and R. I. Fox. 1989. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 169:2191-2198.
70. Salmons, B., and W. H. Gunzburg. 1987. Current perspectives in the biology of mouse mammary tumour virus. Virus Res. 8:81-102.
71. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature (London) 375:802-806.
72. Subramanyam, M., B. McLellan, N. Labrecque, R. P. Sekaly, and B. T. Huber. 1993. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J. Immunol. 151:2538-2545.
73. Sub, W. K., M. F. Cohen-Doyle, K. Fruh, K. Wang, P. A. Peterson, and D. B. Williams. 1994. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322-1326.
74. Sumida, T., T. Sakamaki, F. Yonaha, T. Maeda, T. Namekawa, Y. Nawata, K. Takabavashi, I. Iwamoto, and S. Yoshida. 1994. HLA-DR alleles in patients with Sjogren's syndrome over-representing Vβ2 and Vβ13 genes in the labial salivary glands. Br. J. Rheumatol. 33:420-424.
75. Sumida, T., F. Yonaha, T. Maeda, E. Tanabe, T. Koike, H. Tomioka, and S. Yoshida. 1992. T cell receptor repertoire of infiltrating T cells in lips of Sjogren's syndrome patients. J. Clin. Invest. 89:681-685.
76. Sutkowski, N., T. Palkama, C. Ciurli, R.-P. Sekaly, D. A. Thorley-Lawson, and B. T. Huber. An Epstein-Barr virus-associated superantigen. J. Exp. Med., in press.
77. Sutkowski, N., D. A. Thorley-Lawson, and B. T. Huber. 1996. The interplay of herpesviruses in AIDS: superantigen sharing. Trends Microbiol. 4:89-91.
78. Thorley-Lawson, D. A., L. Chess, and J. L. Strominger, 1977. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human lymphocytes. J. Exp. Med. 146:495-508.
79. Tomkinson, B. E., R. Maziarz, and J. L. Sullivan. 1989. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J. Immunol. 143:660-670.
80. Tomkinson, B. E., D. K. Wagner, D. L. Nelson, and J. L. Sullivan. 1987. Activated lymphocytes during acute Epstein-Barr virus infection. J. Immunol. 139:3802-3807.
81. + T cells. J. Immunol. 150:5519-5528.
82. Tsiagbe, V. K., T. Yoshimoto, J. Asakawa, S. Y. Cho, D. Meruelo, and G. J. Thorbecke. 1993. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 12:2313-2320.
83. Veronese, M. L., A. Veronesi, L. Bruni, V. Coppola, E. D'Andrea, M. A. Del, S. Mezzalira, M. Montagna, G. Ruffatto, A. Amadori, et al. 1994. Properties of tumors arising in SCID mice injected with PBMC from EBV-positive donors. Leukemia 8:214-217.
84. Veronese, M. L., A. Veronesi, E. D'Andrea, A. Del Mistro, S. Indraccolo, M. R. Mazza, M. Mion, R. Zamarchi, C. Menin, M. Panozzo, A. Amadori, and L. Chieco-Bianchi. 1992. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J. Exp. Med. 176:1763-1767.
85. Veronesi, A., V. Coppola, M. L. Veronese, C. Menin, L. Bruni, E. D'Andrea, M. Mion, A. Amadori, and L. Chieco-Bianchi. 1994. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell-injected SCID mice. II. Role of host and donor factors in tumor generation. Int. J. Cancer 59:676-683.
86. von Knebel Doeberitz, M., G. W, Bornkamm, and H. zur Hausen. 1983. Establishment of spontaneously outgrowing lymphoblastoid cell lines with cyclosporin A. Med. Microbiol. Immunol. 172:87-99.
87. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35.
88. Winslow, G. M., M. T. Scherer, J. W. Kappler, and P. Marrack. 1992. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a). Cell 71:719-730.
89. Woodland, D. L., M. P. Happ, K. J. Gollob, and E. Palmer. 1991. An endogenous retrovirus mediating deletion of αβ cells? Nature (London) 349:529-530.
90. Woodland, D. L., F. E. Lund, M. P. Happ, M. A. Blackman, E. Palmer, and R. B. Corley. 1991. Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci. J. Exp. Med. 174:1255-1258.
91. Woodland, D. L., H. P. Smith, S. Surman, P. Le, R. Wen, and M. A. Blackman. 1993. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J. Exp. Med. 177:433-442.
92. Yonaha, F., T. Sumida, T. Maeda, H. Tomioka, T. Koike, and S. Yoshida. 1992. Restricted junctional usage of T cell receptor Vβ2 and Vβ13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjogren's syndrome. Arthritis Rheum. 35:1362-1367.